Diffusion Pharmaceuticals Executives

DFFNDelisted Stock  USD 3.27  0.17  5.48%   
Diffusion Pharmaceuticals employs about 13 people. The company is managed by 10 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 1.3 employees per reported executive. Analysis of Diffusion Pharmaceuticals' management performance can provide insight into the firm performance.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Diffusion Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.3824) % which means that it has lost $0.3824 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6396) %, meaning that it created substantial loss on money invested by shareholders. Diffusion Pharmaceuticals' management efficiency ratios could be used to measure how well Diffusion Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Diffusion Pharmaceuticals Workforce Comparison

Diffusion Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 485. Diffusion Pharmaceuticals holds roughly 13.0 in number of employees claiming about 2.68% of equities under Health Care industry.

Diffusion Pharmaceuticals Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Diffusion Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Diffusion Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Diffusion Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Diffusion Pharmaceuticals Notable Stakeholders

A Diffusion Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Diffusion Pharmaceuticals often face trade-offs trying to please all of them. Diffusion Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Diffusion Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dr CobuzziCEO PresProfile
Suzanne CassidyDirector AssuranceProfile
Jennifer LlewelynDirector CMCProfile
Christopher MDChief OfficerProfile
Harry CookVP OperationsProfile
Kelly HoyDirector ManagementProfile
William JDGen SecProfile
Raven MSChief OfficerProfile
David MDChief Medical Officer and Member of Scientific Advisory BoardProfile
William HornungChief OfficerProfile

About Diffusion Pharmaceuticals Management Performance

The success or failure of an entity such as Diffusion Pharmaceuticals often depends on how effective the management is. Diffusion Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Diffusion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Diffusion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the bodys ability to deliver oxygen. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Diffusion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Diffusion Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Diffusion Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Diffusion Pharmaceuticals within its industry.

Diffusion Pharmaceuticals Manpower Efficiency

Return on Diffusion Pharmaceuticals Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.2M
Net Loss Per Executive1.6M
Working Capital Per Employee1.6M
Working Capital Per Executive2M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Diffusion Stock

If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.